Effects of Different Treatments on Metabolic Syndrome in Patients with Obstructive Sleep Apnea: a Meta-analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Mar 22

PMID 38515989

Authors

Jianing Liu

Jiahuan Xu

Shibo Guan

Wei Wang

Affiliations

Soon will be listed here.

Abstract

Background: Obstructive sleep apnea (OSA) and metabolic syndrome (MetS) often coexist, and the causal relationship between them is not yet clear; treatments for OSA include continuous positive airway pressure (CPAP), mandibular advancement device (MAD), surgery, and lifestyle intervention and so on. However, the effects of different treatments on metabolic syndrome in OSA patients are still under debate.

Objectives: Review the effects of different treatments on metabolic syndrome in OSA patients by meta-analysis.

Methods: we searched articles in PubMed, Embase, Cochrane Library, CNKI, CBM, and Wanfang data from database construction to Feb. 2024.RevMan5.4 and Stata software were used to conduct a meta-analysis of 22 articles.

Results: A total of 22 articles were finally included. The results showed that CPAP treatment could reduce the prevalence of metabolic syndrome in OSA patients in randomized controlled trials (RCTs) (RR = 0.82 [95% CI, 0.75 to 0.90]; < 0.01) and single-arm studies (RR = 0.73 [95% CI, 0.63 to 0.84]; < 0.01). As for metabolic syndrome components, CPAP treatment reduces blood pressure, fasting glucose (FG), triglycerides (TG), and waist circumference (WC) but can't affect high-density lipoprotein cholesterol (HDL-C) levels. Lifestyle intervention could significantly reduce the prevalence of metabolic syndrome in OSA patients (RR = 0.60 [95% CI, 0.48 to 0.74]; < 0.01) and can lower blood pressure, fasting glucose, and waist circumference but can't affect the lipid metabolism of OSA patients. Upper airway surgery can only reduce TG levels in OSA patients (MD = -0.74 [95% CI, -1.35 to -0.13]; = 0.02) and does not affect other components of metabolic syndrome. There is currently no report on the impact of upper airway surgery on the prevalence of metabolic syndrome. No study has reported the effect of MAD on metabolic syndrome in OSA patients.

Conclusion: We confirmed that both CPAP and lifestyle intervention can reduce the prevalence of MetS in OSA patients. CPAP treatment can lower blood pressure, fasting glucose, waist circumference, and triglyceride levels in OSA patients. Lifestyle intervention can lower blood pressure, fasting glucose, and waist circumference in OSA patients. Upper airway surgery can only reduce TG levels in OSA patients.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022326857.

References

Gruber A, Horwood F, Sithole J, Ali N, Idris I . Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006; 5:22. PMC: 1636630. DOI: 10.1186/1475-2840-5-22. View

Fahed G, Aoun L, Zerdan M, Allam S, Zerdan M, Bouferraa Y . Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022; 23(2). PMC: 8775991. DOI: 10.3390/ijms23020786. View

Li J, Thorne L, Punjabi N, Sun C, Schwartz A, Smith P . Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res. 2005; 97(7):698-706. DOI: 10.1161/01.RES.0000183879.60089.a9. View

Asoudeh F, Fallah M, Aminianfar A, Djafarian K, Shirzad N, Clark C . The effect of Mediterranean diet on inflammatory biomarkers and components of metabolic syndrome in adolescent girls. J Endocrinol Invest. 2023; 46(10):1995-2004. DOI: 10.1007/s40618-023-02027-1. View

Bonsignore M, Esquinas C, Barcelo A, Sanchez-de-la-Torre M, Paterno A, Duran-Cantolla J . Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J. 2011; 39(5):1136-43. DOI: 10.1183/09031936.00151110. View

Drager L, Lopes H, Maki-Nunes C, Trombetta I, Toschi-Dias E, Alves M . The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One. 2010; 5(8):e12065. PMC: 2920316. DOI: 10.1371/journal.pone.0012065. View

Huang P . A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6):231-7. PMC: 2675814. DOI: 10.1242/dmm.001180. View

Smith D, Cohen A, Ishman S . Surgical management of OSA in adults. Chest. 2015; 147(6):1681-1690. DOI: 10.1378/chest.14-2078. View

Salord N, Fortuna A, Monasterio C, Gasa M, Perez A, Bonsignore M . A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea. Sleep. 2015; 39(1):35-41. PMC: 4678362. DOI: 10.5665/sleep.5312. View

10.

Gaines J, Vgontzas A, Fernandez-Mendoza J, Bixler E . Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev. 2018; 42:211-219. PMC: 6221996. DOI: 10.1016/j.smrv.2018.08.009. View

11.

Hoyos C, Killick R, Yee B, Phillips C, Grunstein R, Liu P . Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. 2012; 67(12):1081-9. DOI: 10.1136/thoraxjnl-2011-201420. View

12.

Kayikcioglu M, Oto A . Control and Management of Cardiovascular Disease in Turkey. Circulation. 2019; 141(1):7-9. DOI: 10.1161/CIRCULATIONAHA.119.037606. View

13.

Trombetta I, Batalha L, Rondon M, Laterza M, Kuniyoshi F, Gowdak M . Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am J Physiol Heart Circ Physiol. 2003; 285(3):H974-82. DOI: 10.1152/ajpheart.01090.2002. View

14.

Assmann G . Genes and dyslipoproteinaemias. Eur Heart J. 1990; 11 Suppl H:4-8. DOI: 10.1093/eurheartj/11.suppl_h.4. View

15.

Mota P, Drummond M, Winck J, Santos A, Almeida J, Marques J . APAP impact on metabolic syndrome in obstructive sleep apnea patients. Sleep Breath. 2010; 15(4):665-72. DOI: 10.1007/s11325-010-0417-5. View

16.

. Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of the upper airway. Report of the American Sleep Disorders Association. Sleep. 1996; 19(2):152-5. View

17.

Mineiro M, da Silva P, Alves M, Papoila A, Marques Gomes M, Cardoso J . The role of sleepiness on arterial stiffness improvement after CPAP therapy in males with obstructive sleep apnea: a prospective cohort study. BMC Pulm Med. 2017; 17(1):182. PMC: 5723049. DOI: 10.1186/s12890-017-0518-z. View

18.

Georgoulis M, Yiannakouris N, Kechribari I, Lamprou K, Perraki E, Vagiakis E . Sustained improvements in the cardiometabolic profile of patients with obstructive sleep apnea after a weight-loss Mediterranean diet/lifestyle intervention: 12-month follow-up (6 months post-intervention) of the "MIMOSA" randomized clinical trial. Nutr Metab Cardiovasc Dis. 2023; 33(5):1019-1028. DOI: 10.1016/j.numecd.2023.02.010. View

19.

Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y . Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007; 131(5):1387-92. DOI: 10.1378/chest.06-1807. View

20.

Parish J, Adam T, Facchiano L . Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med. 2007; 3(5):467-72. PMC: 1978322. View